{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Mansberger SL"],"funding":["Good Samaritan Foundation","NEI NIH HHS","National Eye Institute"],"pagination":["53-62"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8761780"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["236"],"pubmed_abstract":["<h4>Purpose</h4>To determine the change in intraocular pressure (IOP) and ocular hypotensive medication use after cataract extraction in the Medication Group of the Ocular Hypertension Treatment Study.<h4>Design</h4>Secondary analysis of randomized clinical trial data.<h4>Methods</h4>We included 92 participants (n = 149 eyes) of the Medication Group of the Ocular Hypertension Treatment Study who underwent cataract surgery in at least 1 eye during the study and 531 participants (n = 1004 eyes) of the Medication Group who did not undergo cataract surgery. We defined the \"split date\" as the first study visit that cataract surgery was reported for the cataract surgery group and the 15th visit in the control group to equalize the median number of visits. We then compared the 2 groups at visits "],"journal":["American journal of ophthalmology"],"pubmed_title":["Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study."],"pmcid":["PMC8761780"],"funding_grant_id":["UG1 EY025180","UG1 EY025183","UG1 EY025182","UG1 EY025181"],"pubmed_authors":["Ramulu P","Gordon M","Ocular Hypertension Treatment Study group","Mansberger SL","Kass M","Gardiner SK"],"additional_accession":[]},"is_claimable":false,"name":"Cataract Surgery Lowers Intraocular Pressure and Medication Use in the Medication Group of the Ocular Hypertension Treatment Study.","description":"<h4>Purpose</h4>To determine the change in intraocular pressure (IOP) and ocular hypotensive medication use after cataract extraction in the Medication Group of the Ocular Hypertension Treatment Study.<h4>Design</h4>Secondary analysis of randomized clinical trial data.<h4>Methods</h4>We included 92 participants (n = 149 eyes) of the Medication Group of the Ocular Hypertension Treatment Study who underwent cataract surgery in at least 1 eye during the study and 531 participants (n = 1004 eyes) of the Medication Group who did not undergo cataract surgery. We defined the \"split date\" as the first study visit that cataract surgery was reported for the cataract surgery group and the 15th visit in the control group to equalize the median number of visits. We then compared the 2 groups at visits ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-26T04:51:24.71Z","creation":"2025-04-06T11:13:45.669Z"},"accession":"S-EPMC8761780","cross_references":{"pubmed":["34280363"],"doi":["10.1016/j.ajo.2021.07.008"]}}